Detection, Prognosis, and Treatment: delivering clinical solutions: Innovative Treatments

Promising leads from biology-based studies on the critical path to clinical translation, including immunotherapies, drug delivery technologies, gene therapy, new drug development/testing, and new approaches to clinical decision-making.


Preventing Tumor Progression in Women with High-Risk DCIS 2016 (Cycle 22)
  University of California, San Francisco   $956,774
  Award Type: Translational Research
 
Preclinical analysis of MAD28 in inflammatory breast cancer 2016 (Cycle 22)
  University of California, San Diego   $210,715
  Award Type: IDEA
 
Technologies for Augmented Reality Breast Surgery 2016 (Cycle 22)
  Stanford University   $235,100
  Award Type: IDEA
 
UCSF Breast Oncology Program Scientific Retreat 2015 (Cycle 21)
  University of California, San Francisco   $12,000
  Award Type: Joining Forces
 
Localized Probability of Mammographic Masking 2015 (Cycle 21)
  University of California, San Francisco   $124,112
  Award Type: IDEA
 
High-resolution Dynamic PET for Breast Tumor Differentiation 2015 (Cycle 21)
  University of California, Davis   $187,500
  Award Type: IDEA
 
Exploiting Senescence for Breast Cancer Prevention and Treat 2015 (Cycle 21)
  The Burnham Institute for Medical Research   $292,500
  Award Type: IDEA
 
STOP Heart Disease in Breast Cancer Survivors 2015 (Cycle 21)
  Cedars-Sinai Medical Center   $1,122,177
  Award Type: Translational Research
 
Unique camel-human hybrid mAbs against pro-invasive MMP-14 2015 (Cycle 21)
  University of California, Riverside   $241,174
  Award Type: IDEA
 
Identification of novel breast cancer therapeutic antibodies 2015 (Cycle 21)
  SRI International   $299,273
  Award Type: IDEA
 
UCSF Breast Oncology Program Scientific Retreat 2014 (Cycle 20)
  University of California, San Francisco   $8,023
  Award Type: Joining Forces
 
Gut microbiota in association with chemotherapy treatment 2014 (Cycle 20)
  University of Southern California   $246,937
  Award Type: IDEA
 
A Novel TNBC Therapeutic Opportunity: Cystine Addiction 2014 (Cycle 20)
  University of California, San Francisco   $187,500
  Award Type: IDEA
 
Sulindac-derived compounds for breast cancer therapy 2014 (Cycle 20)
  The Burnham Institute for Medical Research   $292,498
  Award Type: IDEA
 
Drug to block double-strand break repair in breast cancer 2014 (Cycle 20)
  Stanford University   $160,500
  Award Type: IDEA
 
Vitamin D Signals Via a Novel Pathway to Inhibit Metastasis 2013 (Cycle 19)
  Stanford University   $236,068
  Award Type: IDEA
 
Intranasal drug delivery for brain metastatic breast cancer 2013 (Cycle 19)
  University of Southern California   $242,382
  Award Type: IDEA
 
Cardiovascular Toxicity Following Aromatase Inhibitor Use 2013 (Cycle 19)
  Kaiser Foundation Research Institute   $501,034
  Award Type: Translational Research
 
Expression Profiling of Circulating Tumor Cells 2013 (Cycle 19)
  University of Southern California   $244,591
  Award Type: IDEA
 
A first-in-class allosteric RAF inhibitor for breast cancer 2013 (Cycle 19)
  University of California, San Diego   $187,500
  Award Type: IDEA
 
Radiation-Induced Migration of Breast Cancer Cells 2013 (Cycle 19)
  Stanford University   $234,189
  Award Type: IDEA
 
Using Epigenetic Changes to Stratify DCIS Biopsies 2012 (Cycle 18)
  University of California, San Francisco   $750,000
  Award Type: Translational Research
 
Predicting Breast Cancer Recurrence to Improve Care 2012 (Cycle 18)
  University of California, San Francisco   $793,022
  Award Type: Translational Research
 
Genetic Predictors of Chemotherapy Toxicity in Breast Cancer 2012 (Cycle 18)
  University of California, San Francisco   $99,998
  Award Type: IDEA
 
Co-Targeting the Notch and EphB4 Receptors in Breast Cancer 2012 (Cycle 18)
  University of Southern California   $243,362
  Award Type: IDEA
 
Host Hypoxia to Treat Breast Cancer Brain Metastasis 2012 (Cycle 18)
  Scripps Research Institute   $284,250
  Award Type: IDEA
 
Combating Breast Cancer with the Wellderly Immune Repertoire 2011 (Cycle 17)
  Scripps Research Institute   $473,750
  Award Type: IDEA-competitive renewal
 
Targeting Histone Acetyltransferase in Triple Negative BC 2011 (Cycle 17)
  Torrey Pines Institute for Molecular Studies   $272,995
  Award Type: IDEA
 
Identifying Novel Drugable Targets Against TNBC 2011 (Cycle 17)
  University of California, San Francisco   $150,000
  Award Type: IDEA
 
Targeting Prolactin as a Novel Treatment for Breast Cancer 2011 (Cycle 17)
  University of California, Riverside   $150,000
  Award Type: IDEA
 
Reducing Surgical Morbidity of Breast Cancer Staging 2011 (Cycle 17)
  Beckman Research Institute of the City of Hope   $272,483
  Award Type: IDEA-competitive renewal
 
Vitamin D and Breast Cancer in Obesity: Therapeutic Trials 2011 (Cycle 17)
  Stanford University   $1,156,701
  Award Type: Translational Research
 
Targeting Brain Metastasis with a Cell-based Approach 2010 (Cycle 16)
  Scripps Research Institute   $284,354
  Award Type: IDEA
 
The Role of ANCCA in Tamoxifen Resistant Breast Cancer 2010 (Cycle 16)
  University of California, Davis   $84,822
  Award Type: Postdoctoral Fellowship
 
Inhibiting Breast Cancer Brain Metastasis with Cilengitide 2010 (Cycle 16)
  Scripps Research Institute   $284,435
  Award Type: IDEA
 
Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors 2010 (Cycle 16)
  University of California, San Francisco   $75,981
  Award Type: Dissertation
 
Enhancing Trastuzumab Therapy with an NK Activating Antibody 2010 (Cycle 16)
  Stanford University   $224,749
  Award Type: IDEA
 
Receptor Re-expression in ER and PR Negative Breast Cancer 2010 (Cycle 16)
  University of Southern California   $18,203
  Award Type: IDEA
 
Measuring Real-World Breast Cancer Outcomes 2010 (Cycle 16)
  Stanford University   $1,066,225
  Award Type: Translational Research
 
Towards Highly Effective Inactivation of HER2-HER3 Signaling 2010 (Cycle 16)
  University of California, San Francisco   $744,957
  Award Type: Translational Research
 
Salivary Biomarkers for Early Detection of Breast Cancer 2010 (Cycle 16)
  University of California, Los Angeles   $123,748
  Award Type: IDEA
 
New Estrogen Receptor Downregulators for Breast Cancer 2010 (Cycle 16)
  University of California, Los Angeles   $150,000
  Award Type: IDEA
 
Multimarker miR Blood Assay for Breast Cancer Detection 2010 (Cycle 16)
  John Wayne Cancer Institute   $265,415
  Award Type: IDEA
 
Breast Cancer Neoadjuvant Chemotherapy Response with miRNA 2010 (Cycle 16)
  Beckman Research Institute of the City of Hope   $249,000
  Award Type: IDEA
 
HER2 Co-Amplified Genes and Treatment Response 2010 (Cycle 16)
  University of Southern California   $241,988
  Award Type: IDEA
 
A Novel Mediator of AI Resistance in Breast Cancer 2010 (Cycle 16)
  Beckman Research Institute of the City of Hope   $76,000
  Award Type: Dissertation
 
Hec1 Inhibitor Synergizes With Taxol in Breast Cancer 2010 (Cycle 16)
  University of California, Irvine   $0
  Award Type: Postdoctoral Fellowship
 
Targeting Drug Resistant Breast Cancer by microRNAs 2010 (Cycle 16)
  University of California, Los Angeles   $100,000
  Award Type: IDEA
 
6th Symposium on the Intraductal Approach to Breast Cancer 2009 (Cycle 15)
  Dr. Susan Love Research Foundation   $25,000
  Award Type: Joining Forces
 
Antibody-based Targeting of Breast Cancer Stem Cells 2009 (Cycle 15)
  University of California, Santa Barbara   $150,000
  Award Type: IDEA
 
Inhibitors of Condensin I as Chemotherapy for Breast Cancer 2009 (Cycle 15)
  University of California, Irvine   $100,000
  Award Type: IDEA
 
Compounds Blocking Assembly of LRH-1 in Breast Cancer 2009 (Cycle 15)
  University of California, San Francisco   $90,000
  Award Type: Postdoctoral Fellowship
 
Modulation of Breast Cancer Stem Cell Response to Radiation 2009 (Cycle 15)
  University of California, Los Angeles   $250,000
  Award Type: IDEA-competitive renewal
 
Reducing Surgical Morbidity of Breast Cancer Staging 2009 (Cycle 15)
  University of California, Davis   $149,983
  Award Type: IDEA
 
A Predictive Factor for Eribulin Treatment of Breast Cancer 2009 (Cycle 15)
  University of California, Santa Barbara   $74,988
  Award Type: Dissertation
 
Targeting DNA Repair Function of Breast Cancer Stem Cells 2009 (Cycle 15)
  Scripps Research Institute   $284,660
  Award Type: IDEA
 
Survival in de novo and Recurrent Metastatic Breast Cancer 2009 (Cycle 15)
  Beckman Research Institute of the City of Hope   $249,000
  Award Type: IDEA
 
Metabolite Imaging to Identify Drug Resistant Breast Cancer 2009 (Cycle 15)
  Lawrence Berkeley National Laboratory   $171,892
  Award Type: IDEA
 
Combating Breast Cancer with the Wellderly Immune Repertoire 2009 (Cycle 15)
  Scripps Research Institute   $284,718
  Award Type: IDEA
 
Chemerin as an Immunotherapeutic Agent in Breast Cancer 2009 (Cycle 15)
  Palo Alto Institute for Research & Education   $89,600
  Award Type: Postdoctoral Fellowship
 
Treating BC Brain Metastases with Cytotoxic Lymphocytes 2008 (Cycle 14)
  Torrey Pines Institute for Molecular Studies   $105,538
  Award Type: IDEA
 
Nanotherapy for Breast Cancer Targeting Tumor Macrophages 2008 (Cycle 14)
  The Burnham Institute for Medical Research   $90,000
  Award Type: Postdoctoral Fellowship
 
Treating BC Brain Metastases with Cytotoxic Lymphocytes 2008 (Cycle 14)
  Sidney Kimmel Cancer Center   $186,496
  Award Type: IDEA
 
Novel Anti-HER2 Fragments for Better Detection and Therapy 2008 (Cycle 14)
  University of California, Los Angeles   $38,000
  Award Type: Dissertation
 
Topoisomerase-IIa as a Predictor of Anthracycline Response 2008 (Cycle 14)
  University of Southern California   $405,393
  Award Type: IDEA-competitive renewal
 
Genetics of Tamoxifen Response 2008 (Cycle 14)
  University of California, San Francisco   $803,111
  Award Type: Translational Research
 
Imaging of Novel Stem Cell Therapy Targeting Breast Cancer 2008 (Cycle 14)
  Stanford University   $239,213
  Award Type: IDEA
 
Inhibition of TF Signaling as a Novel Breast Cancer Therapy 2008 (Cycle 14)
  Scripps Research Institute   $284,250
  Award Type: IDEA
 
Intraductal Therapy of DCIS: A Presurgery Study 2007 (Cycle 13)
  Dr. Susan Love Research Foundation   $851,559
  Award Type: Translational Research
 
Determinants of Response to Microtubule Stabilizing Drugs 2007 (Cycle 13)
  Stanford University   $66,302
  Award Type: Postdoctoral Fellowship
 
Novel Cytokine Immunotherapy for Breast Cancer 2007 (Cycle 13)
  University of California, San Diego   $150,000
  Award Type: IDEA
 
Polyamide Inhibitors to Block Estrogen Receptor Function 2007 (Cycle 13)
  California Institute of Technology   $75,600
  Award Type: Dissertation
 
Breast Cancer Treatment Monitoring Combining MRI and Optics 2007 (Cycle 13)
  University of California, San Francisco   $113,166
  Award Type: IDEA
 
Modulation of Breast Cancer Stem Cell Response to Radiation 2007 (Cycle 13)
  University of California, Los Angeles   $149,377
  Award Type: IDEA
 
Engineering EGFR Antagonists for Breast Tumor Targeting 2007 (Cycle 13)
  Stanford University   $75,992
  Award Type: Dissertation
 
Neural Stem Cell Therapy for Breast Cancer Brain Metastases 2007 (Cycle 13)
  Scripps Research Institute   $419,400
  Award Type: IDEA-competitive renewal
 
Mechanisms of HSP90 Inhibitor Action in Breast Cancer 2007 (Cycle 13)
  Beckman Research Institute of the City of Hope   $67,871
  Award Type: Dissertation
 
A Targeted Therapy for Wound-like Breast Cancers 2006 (Cycle 12)
  Stanford University   $232,934
  Award Type: IDEA
 
Real-Time 3D Ultrasound Image-Guidance for Breast Surgery 2006 (Cycle 12)
  Stanford University   $66,141
  Award Type: Dissertation
 
rADDs: Novel Disintegrins Targeting Breast Cancer 2006 (Cycle 12)
  University of Southern California   $244,500
  Award Type: IDEA
 
Vascular Targeting Therapy for Breast Cancer 2006 (Cycle 12)
  Sidney Kimmel Cancer Center   $288,728
  Award Type: IDEA
 
Intraoperative Assessment of Surgical Lumpectomy Margins 2006 (Cycle 12)
  John Wayne Cancer Institute   $268,810
  Award Type: IDEA
 
Inhibition of Brain Metastases in Breast Cancer 2006 (Cycle 12)
  Scripps Research Institute   $464,750
  Award Type: IDEA-competitive renewal
 
Neural Stem Cell Therapy for Breast Cancer Brain Metastases 2006 (Cycle 12)
  Scripps Research Institute   $302,085
  Award Type: IDEA
 
Topoisomerase-IIa as a Predictor of Anthracycline Response 2006 (Cycle 12)
  University of Southern California   $244,499
  Award Type: IDEA
 
Nur77-derived Peptides as a Novel Breast Cancer Therapy 2006 (Cycle 12)
  The Burnham Institute for Medical Research   $286,108
  Award Type: IDEA
 
Inhibition of Breast Cancer Aggressiveness by Cannabidiol 2006 (Cycle 12)
  California Pacific Medical Center Research Institute   $183,000
  Award Type: IDEA
 
Breast Tumor Inhibition by Vitamin D in a Mouse Model 2006 (Cycle 12)
  Stanford University   $234,388
  Award Type: IDEA
 
Artemisinin Disrupts Estrogen Receptor-Alpha and Cell Growth 2006 (Cycle 12)
  University of California, Berkeley   $100,000
  Award Type: IDEA
 
Chemical Inhibitors of Hsp70 for Breast Cancer 2006 (Cycle 12)
  The Burnham Institute for Medical Research   $103,232
  Award Type: Postdoctoral Fellowship
 
Sulforaphane: Its Potential for Treatment of Breast Cancer 2006 (Cycle 12)
  University of California, Santa Barbara   $65,415
  Award Type: Dissertation
 
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs 2005 (Cycle 11)
  University of California, San Diego   $28,404
  Award Type: Postdoctoral Fellowship
 
ID4: a Prognostic Factor of Breast Cancer Metastasis 2005 (Cycle 11)
  John Wayne Cancer Institute   $283,200
  Award Type: IDEA
 
Inhibition of Brain Metastases in Breast Cancer 2005 (Cycle 11)
  Scripps Research Institute   $278,850
  Award Type: IDEA
 
HER3 Infidelity and Resistance to Tyrosine Kinase Inhibitors 2005 (Cycle 11)
  University of California, San Francisco   $150,000
  Award Type: IDEA
 
Inhibition of the BRCA2-RAD51 Interaction in Breast Cancer 2005 (Cycle 11)
  University of California, Irvine   $134,769
  Award Type: Postdoctoral Fellowship
 
An Approach to Antiestrogen Resistance in Breast Cancer 2005 (Cycle 11)
  University of California, San Diego   $132,860
  Award Type: Postdoctoral Fellowship
 
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs 2005 (Cycle 11)
  Scripps Research Institute   $48,253
  Award Type: Postdoctoral Fellowship
 
FKBP Proteins as Molecular Targets in Breast Cancer Therapy 2004 (Cycle 10)
  California Pacific Medical Center Research Institute   $88,906
  Award Type: Postdoctoral Fellowship
 
Apogossypol Derivatives for Breast Cancer Therapy 2004 (Cycle 10)
  The Burnham Institute for Medical Research   $285,764
  Award Type: STEP
 
Her-2/neu-Crosreactive Analogs as Targets for Breast Cancer 2004 (Cycle 10)
  Sidney Kimmel Cancer Center   $371,110
  Award Type: STEP
 
Glycoconjugates: Novel Non-toxic Therapies for Breast Cancer 2003 (Cycle IX)
  Sidney Kimmel Cancer Center   $191,278
  Award Type: IDEA
 
Pilot Studies of Breast Cancer Immunophototherapy 2003 (Cycle IX)
  University of California, Irvine   $99,834
  Award Type: IDEA
 
Inhibition of Breast Cancer Cell Invasion by Natural Indoles 2003 (Cycle IX)
  University of California, Berkeley   $80,000
  Award Type: Postdoctoral Fellowship
 
Preclinical Trials for Breast Cancer 2003 (Cycle IX)
  University of California, Davis   $25,000
  Award Type: Joining Forces
 
Dietary Indole Analogs Inhibit Breast Cancer Cell Invasion 2003 (Cycle IX)
  SRI International   $381,491
  Award Type: STEP
 
Cryptic Peptides-Based Vaccines for Breast Tumor Treatment 2003 (Cycle IX)
  Sidney Kimmel Cancer Center   $371,110
  Award Type: STEP
 
Chinese Herb/Chemotherapy Interactions in Breast Cancer 2003 (Cycle IX)
  University of California, San Francisco   $200,000
  Award Type: STEP
 
Inhibitors of Myc: Novel Drugs for Breast Cancer 2003 (Cycle IX)
  Scripps Research Institute   $277,887
  Award Type: STEP
 
Novel I3C Regulated Cell Cycle Factor in Breast Cancer Cells 2003 (Cycle IX)
  University of California, Berkeley   $150,000
  Award Type: STEP
 
Chemotherapy-Induced Ovarian Damage: Prevention and Impact 2002 (Cycle VIII)
  Stanford University   $82,027
  Award Type: CRC Pilot
 
Chemotherapy-Induced Ovarian Damage: Prevention and Impact 2002 (Cycle VIII)
  University of California, San Francisco   $64,189
  Award Type: CRC Pilot
 
Regulation of SXR and Drug Resistance in Breast Cancer 2002 (Cycle VIII)
  Beckman Research Institute of the City of Hope   $41,984
  Award Type: Dissertation
 
Retinoids in Combination Therapies against Breast Cancer 2002 (Cycle VIII)
  Sidney Kimmel Cancer Center   $389,000
  Award Type: STEP
 
Drug Dose Tailoring Based on Patient-Specific Factors 2002 (Cycle VIII)
  University of California, San Francisco   $11,827
  Award Type: Dissertation
 
Potential New Drug Therapy for Breast Cancer 2002 (Cycle VIII)
  University of California, San Francisco   $199,740
  Award Type: STEP
 
Clotting Breast Cancer 2002 (Cycle VIII)
  University of California, Irvine   $98,986
  Award Type: IDEA
 
PPAR Modulators as Apoptosis Sensitizers for Breast Cancer 2002 (Cycle VIII)
  The Burnham Institute for Medical Research   $456,924
  Award Type: STEP
 
MMP-Directed Synthesis of Invasive Breast Cancer Blockers 2002 (Cycle VIII)
  Scripps Research Institute   $135,298
  Award Type: IDEA
 
Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy 2002 (Cycle VIII)
  The Burnham Institute for Medical Research   $378,972
  Award Type: STEP
 
TR3-based Peptides for Apoptosis in Breast Cancer 2002 (Cycle VIII)
  The Burnham Institute for Medical Research   $380,825
  Award Type: STEP
 
Engineering Antibodies Specific for Breast Cancer Proteases 2001 (Cycle VII)
  University of California, San Francisco   $20,193
  Award Type: Postdoctoral Fellowship
 
Selective Targeting of Breast Cancer with Radioiodide 2001 (Cycle VII)
  Stanford University   $315,200
  Award Type: STEP
 
A New Genetic Vaccine Therapy for Breast Cancer 2001 (Cycle VII)
  University of California, Irvine   $100,000
  Award Type: STEP
 
Blood Vessel Markers in Breast Cancer 2001 (Cycle VII)
  The Burnham Institute for Medical Research   $378,655
  Award Type: STEP
 
Dietary Indole Effect on Estrogen Urinary Metabolites 2001 (Cycle VII)
  University of California, Berkeley   $89,925
  Award Type: TRC Pilot
 
Enhanced HER-2 Directed Liposomal Therapeutics 2001 (Cycle VII)
  California Pacific Medical Center Research Institute   $332,938
  Award Type: New Investigator
 
Patient-Individualized Chemotherapy in Breast Cancer 2001 (Cycle VII)
  University of California, Los Angeles   $296,994
  Award Type: New Investigator
 
Protein Factor PPARg & Vitamin A Compounds in Breast Cancer 2001 (Cycle VII)
  The Burnham Institute for Medical Research   $85,218
  Award Type: Postdoctoral Fellowship
 
PPARd Ligands for Inhibition of Breast Cancer Progression 2001 (Cycle VII)
  SRI International   $192,842
  Award Type: STEP
 
Novel Technologies to Identify Tissue-Selective Estrogens 2001 (Cycle VII)
  University of California, San Francisco   $75,000
  Award Type: IDEA
 
In Vivo Effects of Chinese Herbal Extracts on Breast Cancer 2001 (Cycle VII)
  University of California, San Francisco   $199,600
  Award Type: STEP
 
Targeting the EphB4 Receptor to Inhibit Breast Tumor Growth 2001 (Cycle VII)
  The Burnham Institute for Medical Research   $184,576
  Award Type: STEP
 
Herba Scutellaria Barbatae for Metastatic Breast Cancer 2001 (Cycle VII)
  University of California, San Francisco   $232,364
  Award Type: STEP
 
Novel Inhibitors of Rad51-DNA Repair in Breast Cancer 2001 (Cycle VII)
  Pangene Corporation   $130,332
  Award Type: STEP
 
Enhanced HER-2 Directed Liposomal Therapeutics 2001 (Cycle VII)
  Hermes Biosciences, Inc.   $131,823
  Award Type: New Investigator
 
Breast Cancer Prevention by Analogs of EGCG from Green Tea 2000 (Cycle VI)
  SRI International   $296,115
  Award Type: IDEAS II
 
A New Class of Drugs to Treat Breast Cancer 2000 (Cycle VI)
  University of California, San Francisco   $33,694
  Award Type: Postdoctoral Fellowship
 
Cell-Based Immunotherapy for Breast Cancer 2000 (Cycle VI)
  University of California, San Francisco   $120,811
  Award Type: New Investigator
 
Stress Protein and Drug Resistance in Human Breast Cancer 2000 (Cycle VI)
  University of Southern California   $325,873
  Award Type: IDEAS II
 
Identifying the Breast Cancer Target for Indole-3-Carbinol 2000 (Cycle VI)
  University of California, Berkeley   $40,000
  Award Type: Postdoctoral Fellowship
 
A Patient Decision Support Framework for Breast Cancer 2000 (Cycle VI)
  University of California, San Francisco   $148,400
  Award Type: IDEAS II
 
Targeted Chemotherapy to Treat Breast Cancer 2000 (Cycle VI)
  University of California, San Francisco   $200,000
  Award Type: IDEAS II
 
Targeted Delivery of an Anti-breast Tumor Agent 2000 (Cycle VI)
  University of Southern California   $684,291
  Award Type: TRC Full
 
Computer-Aided Discovery of Novel Breast Cancer Therapeutics 2000 (Cycle VI)
  Molecular Research Institute   $112,041
  Award Type: SPRC Exploratory
 
Wnt Signaling in Breast Cancer: Translational Studies 2000 (Cycle VI)
  University of California, Irvine   $328,129
  Award Type: TRC Full
 
Chinese Herbal Therapy (CHT) for Symptom Management 2000 (Cycle VI)
  University of California, San Francisco   $200,000
  Award Type: IDEAS II
 
Role of p14ARF in Metastatic Breast Cancer 2000 (Cycle VI)
  Sidney Kimmel Cancer Center   $365,000
  Award Type: IDEAS II
 
Novel Anti-Angiogenic Agents for Breast Cancer Therapy 2000 (Cycle VI)
  SRI International   $366,022
  Award Type: IDEAS II
 
Arginine Deiminase as an Innovative Anti-Breast Cancer Agent 2000 (Cycle VI)
  University of Southern California   $81,507
  Award Type: IDEA
 
Novel Agents for Treatment of Advanced Breast Cancer 2000 (Cycle VI)
  SRI International   $388,866
  Award Type: IDEAS II
 
Thrombosis for Anti-angiogenic Therapy of Breast Cancer 2000 (Cycle VI)
  University of California, Irvine   $199,633
  Award Type: IDEAS II
 
SXR: A Novel Target for Breast Cancer Therapeutics 1999 (Cycle V)
  University of California, Irvine   $58,132
  Award Type: Postdoctoral Fellowship
 
Can Molecular Markers Predict Response to Adjuvant Therapy 1999 (Cycle V)
  Kaiser Foundation Research Institute   $260,545
  Award Type: TRC Full
 
Can Molecular Markers Predict Response to Adjuvant Therapy? 1999 (Cycle V)
  University of Southern California   $508,813
  Award Type: TRC Full
 
HER2/Neu DNA Vaccines for Breast Cancer 1999 (Cycle V)
  University of California, San Francisco   $197,249
  Award Type: IDEAS II
 
Indole Derivatives as Novel Breast Cancer Therapeutics 1999 (Cycle V)
  University of California, Berkeley   $150,000
  Award Type: IDEAS II
 
How Indole-3 Carbinol Inhibits Breast Cancer Cell Growth 1999 (Cycle V)
  University of California, Berkeley   $35,000
  Award Type: Postdoctoral Fellowship
 
Mechanism of Radiosensitivity in Breast Cancer Cells 1999 (Cycle V)
  Scripps Research Institute   $37,200
  Award Type: Postdoctoral Fellowship
 
New Radiation Therapy for HER-2-overexpressing Breast Cancer 1999 (Cycle V)
  University of California, Los Angeles   $200,000
  Award Type: IDEAS II
 
Breast Cancer Gene Expression Using Amplified Core Biopsies 1999 (Cycle V)
  Stanford University   $155,286
  Award Type: IDEAS II
 
Novel Breast Cancer Anti-Angiogenic Compounds 1999 (Cycle V)
  University of California, Los Angeles   $67,611
  Award Type: IDEA
 
Bispecific Antibodies for Radiotherapy of Breast Cancer 1999 (Cycle V)
  University of California, Davis   $68,615
  Award Type: Postdoctoral Fellowship
 
Laboratory Testing of Chinese Herbs Used for Breast Cancer 1999 (Cycle V)
  University of California, San Francisco   $85,754
  Award Type: IDEAS II
 
Novel Anti-vascular Agents for Breast Cancer Therapy 1998 (Cycle IV)
  SRI International   $353,908
  Award Type: ITaMoCAs
 
Breast Cancer Immunotherapy Using CD4+ Lymphocytes 1998 (Cycle IV)
  University of California, San Diego   $43,289
  Award Type: ITaMoCAs
 
Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer 1998 (Cycle IV)
  University of Southern California   $324,300
  Award Type: ITaMoCAs
 
Molecular Mapping of Surgical Margins 1998 (Cycle IV)
  California Pacific Medical Center Research Institute   $287,992
  Award Type: ITaMoCAs
 
Reduced Breast Cancer Metastasis by Conjugated Linoleic Acid 1998 (Cycle IV)
  University of California, Davis   $199,627
  Award Type: ITaMoCAs
 
Breast Tumor Markers and Response to Adjuvant Therapy 1998 (Cycle IV)
  Kaiser Foundation Research Institute   $77,327
  Award Type: TRC Pilot
 
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis 1998 (Cycle IV)
  University of California, San Diego   $506,070
  Award Type: TRC Full
 
Biologic Determinants of Response to Paclitaxel & Radiation 1998 (Cycle IV)
  University of Southern California   $595,661
  Award Type: TRC Full
 
A New System for Breast Cancer Drug Delivery 1998 (Cycle IV)
  California Pacific Medical Center Research Institute   $73,185
  Award Type: Postdoctoral Fellowship
 
Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy 1998 (Cycle IV)
  Sidney Kimmel Cancer Center   $419,144
  Award Type: New Investigator
 
Heregulin-specific Diphtheria Toxin as a Cancer Therapy 1998 (Cycle IV)
  Salk Institute for Biological Studies   $322,293
  Award Type: New Investigator
 
Breast Cancer Markers and Response to Adjuvant Therapy 1998 (Cycle IV)
  Kaiser Foundation Research Institute   $0
  Award Type: TRC Pilot
 
Breast Tumor Markers and Response to Adjuvant Therapy 1998 (Cycle IV)
  Kaiser Foundation Research Institute   $0
  Award Type: TRC Pilot
 
Biological Determinants of Response to Paclitaxel and Radiat 1998 (Cycle IV)
  Molecular Medicine Research Institute   $0
  Award Type: TRC Full
 
Biological Determinants of Response to Paclitaxel and Radiat 1998 (Cycle IV)
  Molecular Medicine Research Institute   $0
  Award Type: TRC Full
 
Peptide-pulsed Dendritic Cell Therapy for Breast Cancer 1997 (Cycle III)
  University of Southern California   $293,506
  Award Type: ITaMoCAs
 
Gene Therapy for Breast Cancer 1997 (Cycle III)
  California Pacific Medical Center Research Institute   $293,383
  Award Type: ITaMoCAs
 
Inhibitors of the Breast Cancer Her-2/neu Gene 1997 (Cycle III)
  Scripps Research Institute   $342,796
  Award Type: ITaMoCAs
 
Blocking Stromelysin-3 to Inhibit Breast Cancer Metastasis 1997 (Cycle III)
  SRI International   $358,783
  Award Type: ITaMoCAs
 
Superfibronectin: A Novel Anti-Breast Cancer Agent 1997 (Cycle III)
  The Burnham Institute for Medical Research   $389,026
  Award Type: ITaMoCAs
 
Novel drugs to inhibit breast cancer metastasis 1997 (Cycle III)
  University of California, Santa Cruz   $197,064
  Award Type: ITaMoCAs
 
Receptor Antibody-Enhanced Chemotherapy for Breast Cancer 1997 (Cycle III)
  Beckman Research Institute of the City of Hope   $347,674
  Award Type: ITaMoCAs
 
Novel Enzyme Inhibitors for Estrogen-Dependent Breast Cancer 1997 (Cycle III)
  SRI International   $364,820
  Award Type: ITaMoCAs
 
Antibody Fusion Proteins for the Therapy of Breast Cancer 1997 (Cycle III)
  University of California, Los Angeles   $193,224
  Award Type: ITaMoCAs
 
Enhancing breast cancer sensitivity to chemotherapy 1997 (Cycle III)
  Sidney Kimmel Cancer Center   $380,825
  Award Type: ITaMoCAs
 
Targeting T Cells to Breast Cancer 1997 (Cycle III)
  The Burnham Institute for Medical Research   $388,050
  Award Type: ITaMoCAs
 
Biochemical Correlates for Clinical Response to Paclitaxel 1997 (Cycle III)
  University of Southern California   $110,390
  Award Type: TRC Pilot
 
Inhibition of Angiogenesis in Breast Cancer 1997 (Cycle III)
  University of California, San Francisco   $67,830
  Award Type: TRC Pilot
 
The Role of Meltrin-a in Breast Cancer-Associated Bone Loss 1997 (Cycle III)
  The Burnham Institute for Medical Research   $75,600
  Award Type: Postdoctoral Fellowship
 
Modulation of Drug Resistance by Protein Kinase C Inhibitors 1997 (Cycle III)
  Stanford University   $24,182
  Award Type: Postdoctoral Fellowship
 
Breast Cancer Gene Therapy Using a Metastasis Inhibitor 1997 (Cycle III)
  University of Southern California   $75,599
  Award Type: Postdoctoral Fellowship
 
Improved delivery of pharmaceuticals to breast cancer 1996 (Cycle II)
  University of California, San Francisco   $145,492
  Award Type: ITaMoCAs
 
Improved Delivery of Pharmaceuticals to Breast Cancer 1996 (Cycle II)
  California Pacific Medical Center Research Institute   $60,597
  Award Type: ITaMoCAs
 
Pre-clinical cryosurgery testing in breast cancer treatment 1996 (Cycle II)
  University of California, Berkeley   $200,000
  Award Type: ITaMoCAs
 
Targeting Breast Cancer Using Diphtheria Toxin 1996 (Cycle II)
  Salk Institute for Biological Studies   $375,052
  Award Type: ITaMoCAs
 
Structure of EST1: A potential Drug Target for Breast Cancer 1996 (Cycle II)
  University of California, Berkeley   $50,000
  Award Type: ITaMoCAs
 
Novel retinoids that induce apoptosis in breast cancer cells 1996 (Cycle II)
  Sidney Kimmel Cancer Center   $377,091
  Award Type: ITaMoCAs
 
Outpatient Stem Cell Transplants for Breast Cancer 1996 (Cycle II)
  University of California, San Diego   $189,970
  Award Type: ITaMoCAs
 
Tibetan Medicine for Advanced Breast Cancer 1996 (Cycle II)
  University of California, San Francisco   $53,231
  Award Type: ITaMoCAs
 
A New Approach to Immune Therapy for Breast Cancer 1996 (Cycle II)
  University of California, Los Angeles   $204,839
  Award Type: ITaMoCAs
 
T Cell immunotherapy of human breast cancer 1996 (Cycle II)
  University of California, San Diego   $197,305
  Award Type: ITaMoCAs
 
Radiosurgery of early breast cancer 1996 (Cycle II)
  University of Southern California   $76,713
  Award Type: ITaMoCAs
 
Targeted gene therapy using anti-pl85HER2 immunoliposomes 1996 (Cycle II)
  University of California, San Francisco   $205,410
  Award Type: ITaMoCAs
 
Engineered antibodies for imaging & therapy of breast cancer 1996 (Cycle II)
  Beckman Research Institute of the City of Hope   $87,924
  Award Type: IDEA
 
Architecture of the ErbB2 Molecule Leading to Breast Cancer 1996 (Cycle II)
  University of California, San Francisco   $222,349
  Award Type: New Investigator
 
Outpatient Stem Cell Transplants for Breast Cancer 1996 (Cycle II)
  Scripps Clinic & Research Foundation   $0
  Award Type: ITaMoCAs
 
EGFR Structure for Drug Design Targeted to Breast Cancer 1995 (Cycle I)
  University of California, San Diego   $68,730
  Award Type: Postdoctoral Fellowship
 
Blocking Breast Cancer Progression with Radioactive Antibody 1995 (Cycle I)
  University of California, Irvine   $50,000
  Award Type: IDEA
 
Breast Cancer Chemotherapy: Does It Impair Brain Function? 1995 (Cycle I)
  California School of Professional Psychology   $307,456
  Award Type: New Investigator
 
Understanding Tamoxifen - A Drug for Breast Cancer 1995 (Cycle I)
  University of California, San Francisco   $225,000
  Award Type: New Investigator
 
Growth Inhibition of Breast Cancer Cells by Interferons 1995 (Cycle I)
  University of California, Los Angeles   $225,000
  Award Type: New Investigator
 
Breast Cancer Progression and the Extracellular Matrix 1995 (Cycle I)
  University of Southern California   $493,643
  Award Type: Research Project
 
Investigation of Improved Drug Delivery in Breast Cancer 1995 (Cycle I)
  University of California, Irvine   $292,905
  Award Type: Research Project
 
New Endocrine Strategy to Prevent Breast Cancer Progression 1995 (Cycle I)
  University of California, Los Angeles   $263,080
  Award Type: Research Project
 
A Peptide Vaccine for Breast Cancer Prevention 1995 (Cycle I)
  Cytel Corporation   $304,385
  Award Type: Research Project
 
A Peptide Vaccine for Breast Cancer Prevention 1995 (Cycle I)
  Epimmune Inc.   $85,349
  Award Type: Research Project
 
Peptide Vaccines for Immunoprevention of Breast Cancer 1995 (Cycle I)
  University of California, San Diego   $299,886
  Award Type: Research Project
 
Molecular Design for Prevention of Breast Cancer Progression 1995 (Cycle I)
  Cancer Research Institute of Contra Costa   $661,487
  Award Type: Research Project